Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

University of Toronto

$217,088.00

Development of a Magnetic Resonance guided High Intensity Focused Ultrasound Therapy Platform for Perinatal_x000d_ Applications

FY 2020-21

Summary
Congenital abnormalities are complications of pregnancy that can lead to heart failure of the baby and loss of pregnancy. These are diagnosed by ultrasound and can be treated if the risk of fetal death outweighs the risk of surgery. Current therapies all involve minimally invasive access into the uterus and comes with a risk of preterm birth. Magnetic resonance guided high intensity focused ultrasound (MRgHIFU) is a noninvasive therapy that is clinically approved in Canada for thermal ablation of uterine fibroids, and bone metastasis. MRgHIFU transmits ultrasound energy from a transducer located inside a dedicated MRI table that is below the patient, and focuses that energy into the body, producing a thermal lesion as small as a rice kernel. This focus is steered to cover a large treatment volume without repositioning the patient. Since the absorbed energy is nonionizing and incisionless, the risk of infection and long-term side effects are minimal, making it an ideal modality for fetal interventions. However, in the approved devices the energy source is located in configurations that are not adapted for a pregnant mother, and this is not amenable to a safe and ergonomically feasible treatment. The objective of this project is to develop a new modular MRgHIFU robotic platform that brings a HIFU transducer to a patient inside an MRI scanner in a configuration that provides a novel, safe and noninvasive therapy technology for some of our most vulnerable pediatric patients.
Program
Collaborative Health Research Projects
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
538865-2019
Name nom
Waspe, Adam
Department département
Medical Imaging
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
217088
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Installment
inst:2 - 3
Partie
2
Nb partie
3
Application title
Development of a Magnetic Resonance guided High Intensity Focused Ultrasound Therapy Platform for Perinatal_x000d_ Applications
Keyword
NSERC
Application summary
Congenital abnormalities are complications of pregnancy that can lead to heart failure of the baby and loss of pregnancy. These are diagnosed by ultrasound and can be treated if the risk of fetal death outweighs the risk of surgery. Current therapies all involve minimally invasive access into the uterus and comes with a risk of preterm birth. Magnetic resonance guided high intensity focused ultrasound (MRgHIFU) is a noninvasive therapy that is clinically approved in Canada for thermal ablation of uterine fibroids, and bone metastasis. MRgHIFU transmits ultrasound energy from a transducer located inside a dedicated MRI table that is below the patient, and focuses that energy into the body, producing a thermal lesion as small as a rice kernel. This focus is steered to cover a large treatment volume without repositioning the patient. Since the absorbed energy is nonionizing and incisionless, the risk of infection and long-term side effects are minimal, making it an ideal modality for fetal interventions. However, in the approved devices the energy source is located in configurations that are not adapted for a pregnant mother, and this is not amenable to a safe and ergonomically feasible treatment. The objective of this project is to develop a new modular MRgHIFU robotic platform that brings a HIFU transducer to a patient inside an MRI scanner in a configuration that provides a novel, safe and noninvasive therapy technology for some of our most vulnerable pediatric patients.
University of Toronto - $217,088 Grant (2020-21) | Canada Spends